Bitter ABS medicine for AYUSH
Manufacturers cry foul as they receive notices from state boards to pay royalty
Maths of Gilead's hepatitis C drug
Why US firm's super expensive drug sofosbuvir costs so much and how it can be made at a tenth of current price
The promise of Dayamani
Adivasi activists, however successful in mobilising grassroots struggles, have seldom been able to make a dent in Parliament. Will Dayamani Barla …
Keeping Internet global and free
With the US pulling out of the control of the Internet, the world is debating a multi-stakeholder model of governance
Why experts want GM freeze
Say regulatory system has grave deficiencies; challenge agriculture ministry’s claims
Iran-India gas pipeline laid low by geopolitics
Mani Shankar Aiyar is known for the many controversies sparked by his provocative comments and controversial ideas. As Minister for Petroleum and …
Yale guide to fighting drug patent barriers
How human rights can be used to challenge oppressive intellectual property laws
Agroecology is the only way
Rajasthan scraps seed pacts
ICAR tells Rajasthan to wait for guidelines on benefit sharing, biosafety
US plays dirty on tar sands
The EU appears to have backed off on important climate change policy because of pressure from US-backed Big Oil
G8 and tragedy of Africa
Rich nations are forcing African states to change laws to facilitate private investment in agriculture in a replay of colonial adventurism
Evergreen Novartis
The Swiss pharma giant’s challenge to India’s patent law, now in the Supreme Court, may help define drug efficacy
Annihilation of caste and copyright claims
Ambedkar’s works have been published widely and yet pose a copyright conundrum
How I stopped worrying and learned to love Fukushima
Cipla's audacious move
Why generics maker Cipla has asked government to revoke Novartis patent on respiratory ailment drug
Flame in the rainforest
LATHA JISHNU discovers how indigenous communities in Ecuador are fighting to protect Amazonia from oil extraction
Monsanto does it again
The biotech seed giant sues a farmer for planting unbranded commodity seeds bought in the open market for patent infringement
Memories of Agent Orange
Gunning for green tech
US continues to target India over its intellectual property regime, especially in pharma, green tech sectors
Debating science risks
Chinese scientists appear to be more open to discussing the risks and ethics of new technologies than their Indian counterparts
Crazy GM patent system
The Brazilian lawsuit against Monsanto’s royalty on soybean seeds exposes the irrational way in which laws apply to GM crops
Righting the copywrong
Amending the Copyright Act to give directors, composers and musicians rights over their work has corrected a historic wrong but trouble is brewing
A plant breeder comes into his own
Awards are finally coming to K Vinod Prabhu, 54, a plant breeder, for his work on building resistance in wheat, mustard and rice through the …
Who is watching GM crops?
As India gets ready to unleash a vast number of genetically modified (GM) food crops, politicians have joined activists in opposing engineered …
Getting more with less
System of crop intensification, specially in rice, has shown sizeable savings in water and seed usage. Yet its adoption has not spread despite …